# Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography

> **NCT00793182** · PHASE4 · TERMINATED · sponsor: **Guerbet** · enrollment: 6 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** Ioversol 320 mgI/mL
- **DRUG:** Iodixanol 320 mgI/mL

## Key facts

- **NCT ID:** NCT00793182
- **Lead sponsor:** Guerbet
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2019-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00793182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00793182, "Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00793182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*